Related Experiment Video
Updated: Aug 14, 2026

Endoscopic Endonasal Trans-sphenoidal Approach: Minimally Invasive Surgery for Pituitary Adenomas
Published on: January 17, 2018
The Landmark Series: Management of Small Bowel Neuroendocrine Tumors
Catherine G Tran1, Scott K Sherman1, James R Howe2
1Division of Surgical Oncology and Endocrine Surgery, Department of Surgery, University of Iowa Carver College of Medicine, Iowa City, IA, USA.
Abstract:
Surgical resection is the foundation for treatment of small bowel neuroendocrine tumors (SBNETs). Guidelines for surgical management of SBNETs rely on retrospective data, which suggest that primary tumor resection and cytoreduction improve symptoms, prevent future complications, and lengthen survival. In advanced NETs, improvement in progression-free survival has been reported in large, randomized, controlled trials of various medical treatments, including somatostatin analogues, targeted therapy, and peptide receptor radionuclide therapy. This review discusses important studies influencing the management of SBNETs and the limitations of current evidence regarding surgical interventions for SBNETs.
Insights
Surgical resection is key for small bowel neuroendocrine tumors (SBNETs), improving symptoms and survival. Current guidelines lack robust evidence, highlighting the need for more research on surgical interventions for SBNETs.
Area of Science:
- Gastroenterology
- Surgical Oncology
- Endocrinology
Background:
- Small bowel neuroendocrine tumors (SBNETs) are primarily managed with surgical resection.
- Current surgical management guidelines are based on retrospective data.
- Advanced neuroendocrine tumors (NETs) have shown improved progression-free survival with medical therapies.
Purpose of the Study:
- To review key studies influencing the surgical management of SBNETs.
- To identify limitations in the current evidence base for SBNET surgical interventions.
Main Methods:
- Literature review of studies impacting SBNET management.
- Analysis of evidence supporting surgical resection and cytoreduction.
- Examination of data from randomized controlled trials on medical treatments for advanced NETs.
Main Results:
- Retrospective data suggest primary tumor resection and cytoreduction improve symptoms, prevent complications, and prolong survival in SBNETs.
- Medical treatments like somatostatin analogues, targeted therapy, and PRRT have demonstrated efficacy in advanced NETs.
- Significant limitations exist in the evidence supporting specific surgical interventions for SBNETs.
Conclusions:
- Surgical resection remains foundational for SBNET treatment.
- Further research is needed to strengthen the evidence base for surgical interventions in SBNET management.
- Integrating surgical and medical treatment strategies is crucial for advanced SBNETs.

